...
首页> 外文期刊>Ophthalmic Research: Journal for Research in Experimental and Clinical Ophthalmology >Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses.
【24h】

Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses.

机译:苯达扎酸赖氨酸抑制人晶状体上皮细胞粘附于聚甲基丙烯酸甲酯人工晶状体。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the present work was to evaluate the effect of bendazac lysine on the human lens epithelial cell line HLE-B3 adhesion to polymethylmethacrylate (PMMA) intraocular lenses (IOLs). After adherence to IOLs, cells were incubated in the presence of the drug for 24 h. The number of cells contained in a 6-mm(2) area was then counted with an inverted phase microscope and adherent cells were distinguished from detached floating cells by focusing through the medium. Results obtained show that bendazac is able to induce a linear dose-dependent inhibition of HLE-B3 adhesiveness to PMMA IOLs. In particular, treatment with bendazac 33, 100 and 300 microM resulted in a 15, 32 and 54% inhibition, respectively. Statistical analysis shows that this effect is significant at 100 microM (p < 0.05) and 300 microM (p < 0.01). The analysis of the effects of bendazac on the viability and on the proliferative capacity of HLE-B3 cells did not show any drug-related toxicity up to the concentration of 400 microM. The present study demonstrates that bendazac lysine is able to inhibit adhesion of lens epithelial cells to PMMA IOLs and suggests the potential beneficial use of this drug in preventing secondary cataract development.
机译:本工作的目的是评估苯达唑赖氨酸对人晶状体上皮细胞系HLE-B3对聚甲基丙烯酸甲酯(PMMA)人工晶状体(IOL)的粘附作用。粘附IOL后,将细胞在药物存在下孵育24小时。然后用反相显微镜对6毫米(2)区域中包含的细胞数进行计数,并通过聚焦于培养基将粘附细胞与分离的漂浮细胞区分开。获得的结果表明,苯达扎克能够诱导HLE-B3对PMMA IOL的线性剂量依赖性抑制。特别地,用苯达唑33、100和300 microM进行处理分别导致15%,32%和54%的抑制。统计分析表明,这种效应在100 microM(p <0.05)和300 microM(p <0.01)时很明显。苯达唑对HLE-B3细胞的活力和增殖能力的影响分析显示,直至400 microM的浓度,均未发现任何与药物相关的毒性。本研究表明苯达唑赖氨酸能够抑制晶状体上皮细胞与PMMA IOL的粘附,并表明该药物在预防继发性白内障发展中的潜在有益用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号